Table 4 (cont'd)

Patient
No.

& sex

Age at
surgery

Years post
exposure

Pathologic
diagnosis

Remarks

Utirik exposed

2229 F

32

15 1/2

Follicular carcinoma

2208 F
2212 F

53
53

19
19

2221 F

73

19

2160 F
2150 M

25
34

21 1/2
22

Adenomatous nodules
Adenomatous nodules
with Hurthle cell
adenoma
.
Adenomatous nodules
with follicular
adenoma

2261x M

50

23 1/2

No diagnostic lesion

2195 F
2215 F

49
58

25 1/2
25 1/2

Adenomatous nodule
Adenomatous nodules

2194 F

2236 M
2193 F

2147 F

2196 F
2239 F
2132 F

59

35
56

30

63
29
28

22

24
25 1/2

25 1/2

26 1/2
27
27

Papillary carcinoma
Follicular adenoma

Divided opinion:

atypical adenoma

Hyperplasia

Hyperplasia,
atypia

focal

Hyperplasia

Papillary carcinoma

Lymph node metastases

Follicular adenoma
Adenomatous nodules

Focal hyperplasia
Papillary hyperplasia

with occult papillary
carcinoma

Adenomatous nodules

Adenomatous nodules
Adenomatous nodules
Adenomatous nodule

Diffuse
Fibrosis

Rongelap unexposed controls
938 F

33

Adenomatous nodule

841 F

41

1007 M

66

Adenomatous nodules
with occult papillary
carcinoma

1573 M
867 F

28
50

829 F

4023 F
1556 F

41

44
34

Adenomatous nodule

Papillary hyperplasia

Papillary carcinoma

Fibrosis, hyperplasia

Papillary carcinoma
Adenomatous nodule

Fibrosis

Adenomatous nodule
No diagnostic lesion

~ 65 -

Papillary hyperplasia

Select target paragraph3